Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10988782
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10988768
TMPRSS6 iRNA compositions and methods of use thereof
granted -
AU 2019328599
Compounds and methods for treating fungal infections
granted -
EP 3807293
PEPTIDE MIT HEMMENDER WIRKUNG AUF NEURONALE EXOZYTOSE
granted -
EP 3807294
PEPTIDE MIT HEMMENDER WIRKUNG AUF MUSKARINREZEPTOR M3
granted -
US 10980746
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
granted -
US 10980780
Methods and compositions of anti-inflammatory drug and dicer activator for treatment of neuronal diseases
granted -
US 10980825
Cyclic dinucleotide
granted -
US 10982203
Modified factor IX polypeptides and uses thereof
granted -
US 10981855
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
granted -
US 10982212
Conserved HBV and HCV sequences useful for gene silencing
granted -
US 10983128
CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy
granted -
US 10980841
Methods and compositions for in vivo induction of pancreatic beta cell formation
granted -
US 10980861
Glucokinase activator compositions for the treatment of diabetes
granted -
US 10980889
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
granted -
US 10982231
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10981906
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 10981915
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10980755
LRH-1 modulators
granted -
US 10981951
Therapeutics for the treatment of glaucoma
granted -
US 10981896
Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase
granted -
US 10982215
Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof
granted -
US 10982221
Plant-derived antibodies and derivatives that reduce risk of antibody-dependent enhancement (ADE) of infection
granted -
US 10982230
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.